Abstract:The unmet medical need of patients with multiple sclerosis (MS) is the inexorable loss of CNS myelin and latterly neurons leading to permanent neurologic disability. Solicitation of endogenous oligodendrocytes progenitor cells, the precursor of oligodendrocytes, to remyelinate axons may abort the onset of disability. In female mice with experimental autoimmune encephalomyelitis (EAE), a murine model of MS, adoptive transfer of IL-10+ regulatory B cells (Bregs) has been shown to reverse EAE by promoting the expansion of peripheral and CNS-infiltrating IL-10+ T cells. Here, we examined whether Bregs treatment and its bystander effect on regulatory T cells are associated with CNS repair as reflected by oligodendrogenesis and remyelination. We have found that transfusion of Bregs reverses established clinical EAE and that clinical improvement is associated with a significant increase in spinal cord remyelination as reflected by g-ratio analysis within the thoracic and lumbar spine. We further observed in the spinal cords of EAE Bregs-treated mice that CNS resident CD11b/CD45intLy6C– microglia, and infiltrating CD11b+/CD45high monocytes/macrophages content reverts to normal and polarize to a M2-like CD206+ phenotype. Concurrently, there was a substantial increase in neo-oligodendrogenesis as manifest by an increase in CD45–/low CNS cells expressing A2B5, an early marker in oligodendrocytes progenitor cell differentiation as well as GalC+/O1+ premyelinating and myelin basic protein+/myelin oligodendrocyte glycoprotein+ mature oligodendrocytes with reciprocal downregulation of paired related homeobox protein 1. These results demonstrate that the clinical benefit of Bregs is associated with normalization of CNS immune milieu and concurrent activation of oligodendrocyte progenitor cells with subsequent remyelination. SIGNIFICANCE STATEMENT In multiple sclerosis patients, demyelination progresses with aging and disease course, leading to irreversible disability. In this study, we have discovered, using a mouse model of multiple sclerosis, that the transfusion of autologous regulatory B cells (Bregs) is able to ameliorate, cure, and sustain the durable remission of the disease. We show that the adoptive transfer of Bregs dramatically decreased the frequency of myeloid-derived cells, both infiltrating monocytes/macrophages and resident microglia, and converted their phenotype to an immunosuppressive-like phenotype. Moreover, we showed that CNS oligodendrocyte progenitor cells are activated following Bregs treatment and differentiate into myelinating oligodendrocytes, which results in neo-oligodendrogenesis and remyelination of spinal cords.

Immunoglobulin directly enhances differentiation of oligodendrocyte-precursor cells and remyelination

Human Monoclonal IgM Antibody Promotes CNS Myelin Repair Independent of Fc Function

Follicular CD8+ T cells promote immunoglobulin production and demyelination in multiple sclerosis and a murine model

The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders

The Role of Antibodies in the Pathogenesis of Multiple Sclerosis

Regulatory B Cells Normalize CNS Myeloid Cell Content in a Mouse Model of Multiple Sclerosis and Promote Oligodendrogenesis and Remyelination

Pharmacological treatment promoting remyelination enhances motor function after internal capsule demyelination in mice

Myelin-reactive B cells exacerbate CD4+ T cell-driven CNS autoimmunity in an IL-23-dependent manner

B Cells Influence Encephalitogenic T Cell Frequency to Myelin Oligodendrocyte Glycoprotein (MOG)38-49 during Full-length MOG Protein-Induced Demyelinating Disease

Protective and Therapeutic Role of Bilobalide in Cuprizone-Induced Demyelination

Preventing production of new oligodendrocytes impairs remyelination and sustains behavioural deficits after demyelination

IL-10-providing B cells govern pro-inflammatory activity of macrophages and microglia in CNS autoimmunity

Modified Recombinant Human Igg1-Fc Is Superior To Natural Intravenous Immunoglobulin At Inhibiting Immune-Mediated Demyelination

Myelin-Basic Protein-reactive Specific CD4+ and CD8+ NK Lymphocytes Induce Morphological Changes in Neuronal Cell Bodies and Myelin Sheaths: Implications for Multiple Sclerosis

Immunoglobulin G and Complement as Major Players in the Neurodegeneration of Multiple Sclerosis

Ginsenoside Rg1 promotes remyelination and functional recovery in demyelinating disease by enhancing oligodendrocyte precursor cells-mediated myelin repair

Cell-based remyelinating therapy in inflammatory demyelinating injury of the CNS

Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1

IL4I1 augments CNS remyelination and axonal protection by modulating T cell driven inflammation

Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells

Lingo-1 Antagonist Promotes Spinal Cord Remyelination and Axonal Integrity in Mog-Induced Experimental Autoimmune Encephalomyelitis